Xencor Inc (XNCR)
18.50
-0.52
(-2.73%)
USD |
NASDAQ |
Apr 25, 09:46
Xencor Profit Margin (Quarterly): -42.74% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -42.74% |
| September 30, 2023 | -41.02% |
| June 30, 2023 | -48.23% |
| March 31, 2023 | -320.4% |
| December 31, 2022 | -55.72% |
| September 30, 2022 | -120.0% |
| June 30, 2022 | -112.6% |
| March 31, 2022 | 27.60% |
| December 31, 2021 | 47.44% |
| September 30, 2021 | -204.2% |
| June 30, 2021 | 77.47% |
| March 31, 2021 | -7.32% |
| December 31, 2020 | -32.71% |
| September 30, 2020 | -35.49% |
| June 30, 2020 | -267.5% |
| March 31, 2020 | -24.93% |
| December 31, 2019 | -765.4% |
| September 30, 2019 | -46.99% |
| June 30, 2019 | -82.29% |
| March 31, 2019 | 71.51% |
| December 31, 2018 | -157.4% |
| September 30, 2018 | 10.85% |
| June 30, 2018 |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | 24.43% |
| September 30, 2017 | |
| June 30, 2017 | -61.80% |
| March 31, 2017 | -442.1% |
| December 31, 2016 | 44.51% |
| September 30, 2016 | -103.3% |
| June 30, 2016 | 71.45% |
| March 31, 2016 | -88.22% |
| December 31, 2015 | 35.66% |
| September 30, 2015 | -286.5% |
| June 30, 2015 | -874.6% |
| March 31, 2015 | -432.2% |
| December 31, 2014 | -23.82% |
| September 30, 2014 | -740.3% |
| June 30, 2014 | -612.1% |
| March 31, 2014 | -171.7% |
| December 31, 2013 | -212.3% |
| September 30, 2013 | -58.03% |
| June 30, 2013 | -1.28K% |
| March 31, 2013 | -342.9% |
| December 31, 2012 | -128.3% |
| September 30, 2012 | -164.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-765.4%
Minimum
Dec 2019
77.47%
Maximum
Jun 2021
-108.2%
Average
-46.99%
Median
Sep 2019
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -2.85% |
| Karyopharm Therapeutics Inc | -124.0% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.39% |
| Return on Assets | -15.16% |
| Return on Invested Capital | -18.28% |
| Operating Margin (Quarterly) | -78.34% |
| Return on Net Operating Assets | -86.84% |